Quest Diagnostics Files Definitive Proxy Materials
Ticker: DGX · Form: DEFA14A · Filed: 2026-04-06T16:33:23-04:00
Sentiment: neutral
Topics: proxy-filing, shareholder-materials, sec-filing
TL;DR
Quest Diagnostics dropped proxy materials on 4/6/26. Shareholders vote soon.
AI Summary
Quest Diagnostics Inc. filed a DEFA14A on April 6, 2026, related to additional definitive proxy soliciting materials. The filing includes various documents, such as the main DEFA14A filing, graphic files, and a complete submission text file, totaling over 4MB in size. The company's mailing and business address is 500 Plaza Drive, Secaucus, NJ 07094.
Why It Matters
This filing indicates that Quest Diagnostics is engaging in proxy solicitations, which are crucial for shareholder voting on important company matters.
Risk Assessment
Risk Level: low — This is a routine filing for proxy materials and does not indicate any immediate financial or operational risks.
Key Numbers
- 4005331 — Total Submission Size (bytes) (Indicates the volume of information provided in the filing.)
Key Players & Entities
- QUEST DIAGNOSTICS INC (company) — Filer
- 0001022079 (company) — CIK number
- 2026-04-06 (date) — Filing Date
- 500 PLAZA DRIVE SECAUCUS NJ 07094 (location) — Mailing and Business Address
FAQ
What is the purpose of a DEFA14A filing?
A DEFA14A filing is used for additional definitive proxy soliciting materials and Rule 14(a)(12) material, typically related to shareholder meetings and voting.
When was this specific DEFA14A filing accepted by the SEC?
This filing was accepted on April 6, 2026, at 16:33:23.
What is Quest Diagnostics' CIK number?
Quest Diagnostics' CIK number is 0001022079.
Where is Quest Diagnostics' business address?
Quest Diagnostics' business address is 500 Plaza Drive, Secaucus, NJ 07094.
What type of business is Quest Diagnostics primarily involved in, according to the SIC code?
According to the SIC code 8071, Quest Diagnostics is primarily involved in Services-Medical Laboratories.
Filing Stats: 117 words · 1 min read · ~1 pages · Grade level 17.6 · Accepted 2026-04-06 16:33:23
Filing Documents
- ny20064122x2_defa14a.htm (DEFA14A) — 9KB
- ny20064122x2_nc01.jpg (GRAPHIC) — 1263KB
- ny20064122x2_nc02.jpg (GRAPHIC) — 1572KB
- 0001140361-26-013357.txt ( ) — 3911KB
From the Filing
SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to 240.14a-12 Quest Diagnostics Incorporated (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.